Indeed, postoperative analgesia with PFRM synergistically primed tumor specific CD8+ T cells through promoting DCs maturation, and facilitated CD8+ T cells recognition on residual tumor cells through upregulating MHC-I, exhibiting an excellent anti-tumor recurrence effect (Fig. 1). This evidence concerns the gene CD8A and neoplasm.